U.S. and World Newswire
:
Medical
:
Drugs and Pharmaceuticals
News
deverus, Inc. Partners with eScreen Inc. to Offer First and Only Instrumented Instant Drug Testing Device to Clients
Published: Fri, 04 Jan 2008, 11:28:55 EDT
Through eScreen, deverus, Inc. can now offer its clients a paperless solution to collection facilities.
AUSTIN, Texas - Jan. 4 (SEND2PRESS NEWSWIRE) -- deverus, Inc., the leader in background screening technology, recently announced a partnership with eScreen Inc., a company known for its innovative drug screening technology. After comparing different providers, deverus found that no one could match the selection and quality of products that eScreen had to offer. Through eScreen, deverus will now provide clients with technology that creates a web-based system that delivers faster drug test results and paperless transactions.
In its mission to offer superior technology to its clients, deverus sought out a company that could provide a system that could support high volume with proven results. eScreen, with millions of healthcare and corporate data transactions processed a year, was the answer. As more and more businesses and industries turn to better solutions for maintaining an efficient workforce, drug screening is certain to become indispensable in the hiring process.
"We are excited to partner with the technology leader in the drug screening industry. They share the same commitment to innovation and automation," said Shawn Rucks, CEO of deverus, Inc. "This alliance will benefit our clients greatly and is one more reason why so many background check companies are switching to deverus technology."
Clients of deverus will be able to stay ahead of the curve on technology through eScreen's innovative product line. The drug testing industry is known for being highly fragmented and the drug screening methods often involve time consuming paper management and delays on the test results. eScreen has shown it can offer a swift, electronic, and paperless solution to the standard collection facility. This service is exclusive through eScreen, as it is the only product line of its kind serving the $1.5 billion dollar a year drug testing industry. Robert Thompson, CEO and President of eScreen said, "The integration of drug screening and background check processes is central to providing a state-of-the-art on-boarding experience for hiring managers and job applicants. eScreen's partnership with deverus reinforces the dedication of both companies to provide a solution that meets the evolving demands of HR departments."
deverus and eScreen are committed to furthering the growth and efficiency of the drug screening industry by offering companies a web based solution that goes beyond the paper log by presenting real time drug screening and background check data.
About eScreen
Located in Overland Park, Kansas, eScreen was founded by the nation's largest MRO corporation in 1998. eScreen manufactures and markets the first and only automated instant clinic-based rapid drug testing device.
eScreen offers a rapid, electronic, paperless solution to pre-employment drug testing, vastly surpassing industry standards for test turnaround, consistency and accountability of test methods, and client value.
Please visit www.escreen.com to learn more.
About deverus
Founded in 1998, deverus is the leading provider of software, integration technology, and strategic services for the background check industry. From system-to-system integration, customized and off the shelf enterprise level applications, to sophisticated tools that manage the information supply chain, deverus enables background check companies to dramatically lower operating expenses and increase revenues by connecting to customers, employees, and information sources online, anytime, from anywhere.
NEWS SOURCE: deverus, Inc.
Send2Press® is the originating wire service for this story.
» Read More Drugs and Pharmaceuticals News
» Other Send2Press Industry News by Category
More Information and Media Contact:
For questions about this story, contact the news source:
»
Click Here for Contact Information
THE CONTENT OF THE ABOVE NEWS STORY WAS PROVIDED BY THE NEWS SOURCE WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT SEND2PRESS (THIS WEBSITE).
O T H E R R E S O U R C E S
T E R M S O F U S E
This article is Copr. © 1983-2008 Neotrope / Send2Press. Reproduction of this news article version requires written authorization. You may freely link to this article. Journalists (see the section "Journalist Resources" above) may use orig. news release as the basis for an article.
News Websites may republish the "news release" text version linked to above under "Journalist Resources" except must retain "Send2Press Newswire" as the source of this news if used verbatim. Websites which offer/sell PR or newswire services, or web promotion services, or "splogs" may NOT reprint our content in ANY form. Send2Press Newswire is a service mark of, and "Send2Press" is a registered trademark of, Neotrope. Creative Commons - Some Rights Reserved (3.0) - Attribution Required.
DISCLAIMER: the above article is believed accurate but not guaranteed, and is based on business news supplied by the source (deverus, Inc.). The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope or Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.
REFERENCES: deverus, Inc. Partners with eScreen Inc. to Offer First and Only Instrumented Instant Drug Testing Device to Clients, deverus Inc, eScree, software, integration technology, and strategic services for the background check industry, rapid drug testing device, Jan 4, 2008.
VIEWED BY MEDIA (and public): 1670 times (1 today, 1 this week,
29 this month, 1670 this year)
|
|
|
Subscribe in a reader
PLAIN TEXT FORMAT (UTF-8)
PDF FORMAT
